DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.7600
+0.0101 (1.35%)
At close: May 12, 2025, 4:00 PM
0.7600
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
DarioHealth Revenue
In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth. DarioHealth had revenue of $7.60M in the quarter ending December 31, 2024, with 110.29% growth.
Revenue (ttm)
$27.04M
Revenue Growth
+32.86%
P/S Ratio
1.38
Revenue / Employee
$133,861
Employees
202
Market Cap
31.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
| Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
| Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
| Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
| Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
DRIO News
- 4 days ago - Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations - PRNewsWire
- 5 days ago - DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025 - PRNewsWire
- 11 days ago - DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives - PRNewsWire
- 21 days ago - DarioHealth Announces CFO Transition - PRNewsWire
- 25 days ago - DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers - PRNewsWire
- 4 weeks ago - Top U.S. Healthcare Institution Deploys DarioHealth's Full Suite, Contributing to 2025 Revenue Growth and Market Expansion - PRNewsWire
- 2 months ago - /C O R R E C T I O N -- DarioHealth Corp./ - PRNewsWire
- 2 months ago - DarioHealth Corp. (DRIO) Q4 2024 Earnings Call Transcript - Seeking Alpha